Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
Visco C, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, Medeiros LJ, Notti P, Rassidakis GZ, Peethambaram P, Wilder R, Witzig T, Gianni M, Bonadonna G, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH. Visco C, et al. Among authors: kliche ko. Leuk Lymphoma. 2004 Oct;45(10):2085-92. doi: 10.1080/10428190410001712234. Leuk Lymphoma. 2004. PMID: 15370254
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Herling M, Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, Giardini R, Chilosi M, Kittas C, Gianni AM, Bonadonna G, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH. Herling M, et al. Among authors: kliche ko. Clin Cancer Res. 2003 Jun;9(6):2114-20. Clin Cancer Res. 2003. PMID: 12796376
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
Sarris AH, Kliche KO, Pethambaram P, Preti A, Tucker S, Jackow C, Messina O, Pugh W, Hagemeister FB, McLaughlin P, Rodriguez MA, Romaguera J, Fritsche H, Witzig T, Duvic M, Andreeff M, Cabanillas F. Sarris AH, et al. Among authors: kliche ko. Ann Oncol. 1999 Apr;10(4):433-40. doi: 10.1023/a:1008301602785. Ann Oncol. 1999. PMID: 10370786 Free article. Clinical Trial.
CD30 ligand in lymphoma patients with CD30+ tumors.
Younes A, Consoli U, Snell V, Clodi K, Kliche KO, Palmer JL, Gruss HJ, Armitage R, Thomas EK, Cabanillas F, Andreeff M. Younes A, et al. Among authors: kliche ko. J Clin Oncol. 1997 Nov;15(11):3355-62. doi: 10.1200/JCO.1997.15.11.3355. J Clin Oncol. 1997. PMID: 9363866 Clinical Trial.
Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells.
Clodi K, Asgary Z, Zhao S, Kliche KO, Cabanillas F, Andreeff M, Younes A. Clodi K, et al. Among authors: kliche ko. Br J Haematol. 1998 Oct;103(1):270-5. doi: 10.1046/j.1365-2141.1998.01031.x. Br J Haematol. 1998. PMID: 9792321 Free article.
Cell-surface exposure of phosphatidylserine correlates with the stage of fludarabine-induced apoptosis in chronic lymphocytic leukemia and expression of apoptosis-regulating genes.
Clodi K, Kliche KO, Zhao S, Weidner D, Schenk T, Consoli U, Jiang S, Snell V, Andreeff M. Clodi K, et al. Among authors: kliche ko. Cytometry. 2000 May 1;40(1):19-25. doi: 10.1002/(sici)1097-0320(20000501)40:1<19::aid-cyto3>3.0.co;2-3. Cytometry. 2000. PMID: 10754513 Free article.
33 results